CG Oncology (CGON) Depreciation and Depletion (2024 - 2026)
CG Oncology (CGON) reported Depreciation and Depletion of $800000.0 for Q1 2026, up 700.0% on a YoY basis from $100000.0 in Q1 2025, and little changed quarter-over-quarter from $800000.0 in Q4 2025.
CG Oncology (CGON) Depreciation and Depletion (2024 - 2026) Analysis & Trends
CG Oncology has reported Depreciation and Depletion for 3 years, with the latest figure at $800000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion rose 700.0% year-over-year to $800000.0; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (changed N/A YoY), and the FY2025 full-year result was $1.4 million, up 1300.0% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $800000.0, roughly flat from $800000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $800000.0 in Q4 2025, with the low at $100000.0 in Q3 2024.
- Historically, Depreciation and Depletion has averaged $460000.0 across 3 years, with a median of $500000.0 in 2025.
- Annual changes were most pronounced in 2025 — Depreciation and Depletion soared 400.0% — and 2026, when it jumped 700.0%.
- CG Oncology's Depreciation and Depletion stood at $100000.0 in 2024, then jumped by 700.0% to $800000.0 in 2025, then changed by 0.0% to $800000.0 in 2026.
- The last three Depreciation and Depletion figures came in at $800000.0 (Q1 2026), $800000.0 (Q4 2025), and $500000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | CG Oncology | 5.16 Bn | 5.16 Bn | -1.88 Mn | 800,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 800,000.00 |
| Mar 31, 2026 | 800,000.00 |
| Dec 31, 2025 | 800,000.00 |
| Dec 31, 2025 | 800,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |